Edition:
India

Assembly Biosciences Inc (ASMB.OQ)

ASMB.OQ on NASDAQ Stock Exchange Capital Market

56.82USD
16 Feb 2018
Change (% chg)

$-1.06 (-1.83%)
Prev Close
$57.88
Open
$57.83
Day's High
$58.35
Day's Low
$56.38
Volume
68,271
Avg. Vol
57,991
52-wk High
$58.57
52-wk Low
$18.60

Chart for

About

Assembly Biosciences, Inc. is a biotechnology company. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome. It has... (more)

Overall

Beta: 0.76
Market Cap(Mil.): $613.14
Shares Outstanding(Mil.): 17.36
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.64
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Assembly Biosciences Files For Mixed Shelf Of Up To $250 Mln

* ASSEMBLY BIOSCIENCES FILES FOR MIXED SHELF OF UP TO $250 MILLION - SEC FILING Source text: (http://bit.ly/2CnCeGR) Further company coverage:

30 Dec 2017

BRIEF-Assembly Biosciences Appoints Sue Mahony To Board Of Directors

* ASSEMBLY BIOSCIENCES APPOINTS SUE MAHONY, PHD TO BOARD OF DIRECTORS

19 Dec 2017

BRIEF-Assembly Biosciences prices public offering of 2.21 mln common shares at $27.25 per share

* Assembly biosciences announces pricing of $60 million offering of common stock

02 Nov 2017

Competitors

  Price Chg
Kyowa Hakko Kirin Co Ltd (4151.T) ¥2,322 --

Earnings vs. Estimates